山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (4): 6-11.doi: 10.6040/j.issn.1673-3770.0.2021.195
杨琨1,陈利娟2,何小丹3,刘志奇3,沙素华4
YANG Kun1, CHEN Lijuan2, HE Xiaodan3, LIU Zhiqi3, SHA Suhua4
摘要: 目的 初步比较研究卡那霉素和2-羟丙基-β-环糊精(HPβCD)致CBA/J小鼠耳毒性损伤的特点。 方法 雄性CBA/J小鼠,700 mg/kg卡那霉素连续腹腔注射15 d,HPβCD8 000 mg/kg皮下注射,对照组均为0.9%无菌氯化钠生理盐水。听性脑干反应(ABR)检测听力。耳蜗基底膜铺片和二氨基联苯胺染色法(DAB)毛细胞计数。HPβCD多个时间点听阈的比较和外毛细胞记数的比较使用统计软件GraphPad Prism 13 中重复测量方差分析法(Repeated measures ANOVA)进行数据分析,卡那霉素实验中听阈的比较用GraphPad Prism 13中的双样本t检验(T-Test)。 结果 生理盐水组8 kHz、16 kHz、32 kHz阈值分别为(21±2.24)dB、(21±2.24)dB、(21±2.24)dB;卡那霉素治疗组阈值分别为(22±2.74)dB(t=0.632 5,P=0.544 7)、(67±4.47)dB(t=20.571 8,P<0.001)、(77±4.47)dB(t=25.044 0, P<0.001)。HPβCD治疗组6 h后,8 kHz、16 kHz、32 kHz反应分别为(29±4.18)dB、(30±4.47)dB、(37±2.74)dB,7h时后分别为(65±3.54)dB、(71±2.24)dB、(80±3.54)dB,8 h后分别为(70±3.54)dB、(78±5.70)dB、(85±5.00)dB,经比较显示差异有统计学意义(F=20.590,P<0.001)。随着HPβCD用药时间的延长,各频率听力损失逐渐加重。卡那霉素治疗组OHC损失于顶转至基底转2.0 mm处为(9.17±6.03)%,2.5 mm处为(89.76±3.12)%, 4.0 mm处为100%,经比较显示差异有统计学意义(F=7.840,P=0.000 3);IHC损失分别为(0.71±0.00)%、(6.79±6.01)%、(20.71±6.00)%,经比较显示2.5 mm和4.0 mm处差异有统计学意义(F=3.549,P<0.05)。HPβCD治疗6 h后耳蜗基底膜外毛细胞可见明显的损伤,外毛细胞的损伤在基底膜顶转,中转和底转都可出现,7、8 h后耳蜗内外毛细胞几乎完全脱落,8 h以内未见明显的内毛细胞损伤。 结论 卡那霉素和HPβCD均致小鼠听力下降、毛细胞损伤。卡那霉素耳毒性损伤从高频开始,HPβCD耳毒性听力损伤在早期就波及全频,外毛细胞损伤先于内毛细胞损伤,损伤程度都具有时间和浓度依赖性。
中图分类号:
[1] Stogios PJ, Evdokimova E, Morar M, et al. Structural and functional plasticity of antibiotic resistance nucleotidylyltransferases revealed by molecular characterization of lincosamide nucleotidylyltransferases lnu(A)and lnu(D)[J]. J Mol Biol, 2015, 427(12): 2229-2243. doi:10.1016/j.jmb.2015.04.008. [2] Alobaidy H. Recent advances in the diagnosis and treatment of niemann-pick disease type C in children: a guide to early diagnosis for the general pediatrician[J]. Int J Pediatr, 2015, 2015: 816593. doi:10.1155/2015/816593. [3] Mengel E, Klünemann HH, Lourenço CM, et al. Niemann-Pick disease type C symptomatology: an expert-based clinical description[J]. Orphanet J Rare Dis, 2013, 8(1): 166. doi:10.1186/1750-1172-8-166. [4] Wu WJ, Sha SH, McLaren JD, et al. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat[J]. Hearing Research, 2001, 158:165-178. doi:10.1016/S0378-5955(01)00303-3. [5] Sarah W, Patricia OD, Steven F, et al. 2-hydroxypropyl-β-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease[J]. Pediatr Res,2010, 68(1): 52-56. doi:10.1203/PDR.0b013e3181df4623. [6] Ory DS, Ottinger EA, Farhat, NY, et al. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial[J]. Lancet, 2017, 390, 1758-1768. doi:10.1016/S0140-6736(17)31465-4. [7] Jiang MY, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: a review[J]. Front Cell Neurosci, 2017, 11: 308. doi:10.3389/fncel.2017.00308. [8] Davidson CD, Ali NF, Micsenyi MC, et al. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression[J]. PLoS One, 2009, 4(9): e6951. doi:10.1371/journal.pone.0006951. [9] Liu B, Ramirez CM, Miller AM, et al. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid[J]. J Lipid Res, 2010, 51(5): 933-944. doi:10.1194/jlr.M000257. [10] Kros CJ, Steyger PS. Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies[J]. Cold Spring Harb Perspect Med, 2019, 9(11): a033548. doi:10.1101/cshperspect.a033548. [11] Lee MY, Kabara LL, Swiderski DL, et al. ROS scavenger, ebselen, has no preventive effect in new hearing loss model using a cholesterol-chelating agent[J]. J Audiol Otol, 2019, 23(2): 69-75. doi:10.7874/jao.2018.00255. |
[1] | 何景春1,阮清伟2,韩淼淼1,金斌1,李克勇1,董频1. 应用顺铂建立C57小鼠感音神经性聋模型的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 1-5. |
[2] | 王晓1,鞠宏霜2,梁桂玲1,闫永红1,苏梅1. FK506拮抗庆大霉素耳毒性的实验观察[J]. 山东大学耳鼻喉眼学报, 2010, 24(6): 13-16. |
|